搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Arthroderma benhamiae Subtilisin-like protease 6 (SUB6) CSB-YP514293DOM
CSB-EP514293DOM
CSB-BP514293DOM
CSB-MP514293DOM
CSB-EP514293DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Extracellular metalloprotease ARB_05317 (ARB_05317) CSB-YP514294DOM
CSB-EP514294DOM
CSB-BP514294DOM
CSB-MP514294DOM
CSB-EP514294DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable E3 ubiquitin ligase complex SCF subunit sconB (sconB), partial CSB-YP514295DOM
CSB-EP514295DOM
CSB-BP514295DOM
CSB-MP514295DOM
CSB-EP514295DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable zinc metalloprotease ARB_04732 (ARB_04732) CSB-YP514296DOM
CSB-EP514296DOM
CSB-BP514296DOM
CSB-MP514296DOM
CSB-EP514296DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable neutral protease 2 homolog ARB_04769 (ARB_04769) CSB-YP514297DOM
CSB-EP514297DOM
CSB-BP514297DOM
CSB-MP514297DOM
CSB-EP514297DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Nucleolar protein 9 (NOP9), partial CSB-YP514298DOM
CSB-EP514298DOM
CSB-BP514298DOM
CSB-MP514298DOM
CSB-EP514298DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable zinc metalloprotease ARB_05554 (ARB_05554), partial CSB-YP514299DOM
CSB-EP514299DOM
CSB-BP514299DOM
CSB-MP514299DOM
CSB-EP514299DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Aspartic protease PEP1 (PEP1) CSB-YP514300DOM
CSB-EP514300DOM
CSB-BP514300DOM
CSB-MP514300DOM
CSB-EP514300DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable tripeptidyl-peptidase SED2 (SED2) CSB-YP514301DOM
CSB-EP514301DOM
CSB-BP514301DOM
CSB-MP514301DOM
CSB-EP514301DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable neutral protease 2 homolog ARB_05817 (ARB_05817) CSB-YP514302DOM
CSB-EP514302DOM
CSB-BP514302DOM
CSB-MP514302DOM
CSB-EP514302DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Formation of crista junctions protein 1 (FCJ1), partial CSB-YP514303DOM1
CSB-EP514303DOM1
CSB-BP514303DOM1
CSB-MP514303DOM1
CSB-EP514303DOM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Carboxypeptidase S1 homolog B (SCPB), partial CSB-YP514304DOM
CSB-EP514304DOM
CSB-BP514304DOM
CSB-MP514304DOM
CSB-EP514304DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Subtilisin-like protease 7 (SUB7) CSB-YP514305DOM
CSB-EP514305DOM
CSB-BP514305DOM
CSB-MP514305DOM
CSB-EP514305DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable dipeptidyl peptidase 4 (DPP4), partial CSB-YP514306DOM
CSB-EP514306DOM
CSB-BP514306DOM
CSB-MP514306DOM
CSB-EP514306DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Subtilisin-like protease 11 (SUB11) CSB-YP514307DOM
CSB-EP514307DOM
CSB-BP514307DOM
CSB-MP514307DOM
CSB-EP514307DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Subtilisin-like protease 12 (SUB12) CSB-YP514308DOM
CSB-EP514308DOM
CSB-BP514308DOM
CSB-MP514308DOM
CSB-EP514308DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Subtilisin-like protease 10 (SUB10) CSB-YP514309DOM
CSB-EP514309DOM
CSB-BP514309DOM
CSB-MP514309DOM
CSB-EP514309DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable extracellular metalloproteinase 5 (MEP5) CSB-YP514310DOM
CSB-EP514310DOM
CSB-BP514310DOM
CSB-MP514310DOM
CSB-EP514310DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Probable dipeptidyl-aminopeptidase B (DAPB), partial CSB-YP514311DOM
CSB-EP514311DOM
CSB-BP514311DOM
CSB-MP514311DOM
CSB-EP514311DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arthroderma benhamiae Vacuolar protein sorting/targeting protein 10 (VPS10), partial CSB-YP514312DOM
CSB-EP514312DOM
CSB-BP514312DOM
CSB-MP514312DOM
CSB-EP514312DOM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>